Divis Laboratories announced that the 34th Annual General Meeting (AGM) of the company will be held on 12 August 2024.Powered by Capital Market - Live News

Net profit of Divi`s Laboratories rose 67.60% to Rs 538.00 crore in the quarter ended March 2024 as against Rs 321.00 crore during the previous quarter ended March 2023. Sales rose 18.04% to Rs 2303.00 crore in the quarter ended March 2024 as against Rs 1951.00 crore during the previous quarter ended March 2023.For the full year,net profit declined 12.28% to Rs 1600.00 crore in the year ended March 2024 as against Rs 1824.00 crore during the previous year ended March 2023. Sales rose 1.00% to Rs 7845.00 crore in the year ended March 2024 as against Rs 7767.00 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales2303.001951.00 18 7845.007767.00 1 OPM %31.7424.96 -28.1130.49 - PBDT808.00553.00 46 2541.002712.00 -6 PBT713.00466.00 53 2163.002369.00 -9 NP538.00321.00 68 1600.001824.00 -12 Powered by Capital Market - Live News

Divis Laboratories announced that the Board of Directors of the Company at its meeting held on 25 May 2024, has recommended a Final dividend of Rs.30 per share (i.e.1500%), subject to the approval of the shareholders.Powered by Capital Market - Live News

Divis Laboratories will hold a meeting of the Board of Directors of the Company on 25 May 2024Powered by Capital Market - Live News

Divi`s Laboratories is in the process of entering into a long-term supply agreement with a customer and is planning for capacity addition at its manufacturing facility with an estimated investment between Rs 650 crore to Rs 700 crore, to be funded from internal accruals. The proposed facility is expected to be operational around January, 2027.Powered by Capital Market - Live News